Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis

Declining Genital Warts in Young Women in England Associated With HPV 16/18 Vaccination: An Ecological Study

(2013) Rebecca Howell-Jones et al.   JOURNAL OF INFECTIOUS DISEASES

Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010

(2013) Lauri E. Markowitz et al.   JOURNAL OF INFECTIOUS DISEASES

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

(2013) H. Ali et al.   BMJ-British Medical Journal

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada

(2012) G.S. Ogilvie et al.   VACCINE

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

(2011) Julia ML Brotherton et al.   LANCET

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Matti Lehtinen et al.   LANCET ONCOLOGY

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

(2010) Nubia Muñoz et al.   JNCI-Journal of the National Cancer Institute

Post-licensure monitoring of HPV vaccine in the United States

(2010) Lauri E. Markowitz et al.   VACCINE

A Population-Based Evaluation of a Publicly Funded, School-Based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt

(2010) Gina Ogilvie et al.   PLOS MEDICINE

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

(2009) S. K. Kjaer et al.   Cancer Prevention Research

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women

(2009) C K Fairley et al.   SEXUALLY TRANSMITTED INFECTIONS

Protecting the Next Generation: What Is the Role of the Duration of Human Papillomavirus Vaccine–Related Immunity?

(2008) Oliver P. Günther et al.   JOURNAL OF INFECTIOUS DISEASES

Self-collection of genital human papillomavirus specimens in heterosexual men

(2008) G S Ogilvie et al.   SEXUALLY TRANSMITTED INFECTIONS

Intention of parents to have male children vaccinated with the human papillomavirus vaccine

(2008) G S Ogilvie et al.   SEXUALLY TRANSMITTED INFECTIONS